000 | 01925 a2200529 4500 | ||
---|---|---|---|
005 | 20250516050259.0 | ||
264 | 0 | _c20120716 | |
008 | 201207s 0 0 eng d | ||
022 | _a1526-7598 | ||
024 | 7 |
_a10.1213/ANE.0b013e318227824e _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKim, Woong Mo | |
245 | 0 | 0 |
_aThe intrathecally administered kappa-2 opioid agonist GR89696 and interleukin-10 attenuate bone cancer-induced pain through synergistic interaction. _h[electronic resource] |
260 |
_bAnesthesia and analgesia _cOct 2011 |
||
300 |
_a934-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aBone Neoplasms _xcomplications |
650 | 0 | 4 |
_aBreast Neoplasms _xpathology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aInjections, Spinal |
650 | 0 | 4 |
_aInterleukin-10 _xadministration & dosage |
650 | 0 | 4 |
_aPain _xdrug therapy |
650 | 0 | 4 | _aPain Measurement |
650 | 0 | 4 |
_aPain Threshold _xdrug effects |
650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
650 | 0 | 4 |
_aPyrrolidines _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Opioid, kappa _xagonists |
650 | 0 | 4 |
_aTibia _xpathology |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aJeong, Cheol Won | |
700 | 1 | _aLee, Seong Heon | |
700 | 1 | _aKim, Yeo Ok | |
700 | 1 | _aCui, Jin Hua | |
700 | 1 | _aYoon, Myung Ha | |
773 | 0 |
_tAnesthesia and analgesia _gvol. 113 _gno. 4 _gp. 934-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1213/ANE.0b013e318227824e _zAvailable from publisher's website |
999 |
_c21034858 _d21034858 |